XenaCare Holdings, Inc. (XenaCare) markets and distributes a line of clinical and life style performance, homeopathic medications and nutrition supplement products (NSPs). The Company also markets the SunPill, which was developed to protect the skin when exposed to damaging ultraviolet rays. Its clinical products group includes its formulations - XenaCor, XenaTri and XenaZyme Plus. XenaCare�s products groups have been established to formulate a line of NSPs to be sold through direct response, catalog, mass media (radio and television) magazine advertising, Web sales, mass food and drug retailers and other channels of distribution. In May, 2009, NutraPharma, Inc. awarded to XenaCare the United States marketing rights to Cobroxin. In May, 2009, Mineral Sciences, Inc. awarded XenaCare the license to market and distribute a cellular cleanse at retail and detoxification product called Zeolite for retail distribution designed as a solution for removing heavy metals and toxins from the body.